ATE60589T1 - Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel. - Google Patents

Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel.

Info

Publication number
ATE60589T1
ATE60589T1 AT87401562T AT87401562T ATE60589T1 AT E60589 T1 ATE60589 T1 AT E60589T1 AT 87401562 T AT87401562 T AT 87401562T AT 87401562 T AT87401562 T AT 87401562T AT E60589 T1 ATE60589 T1 AT E60589T1
Authority
AT
Austria
Prior art keywords
trcyclical
cholinergetic
receptors
medicines containing
agonist derivatives
Prior art date
Application number
AT87401562T
Other languages
English (en)
Inventor
Kathleen Biziere
Camille Georges Wermuth
Paul Worms
Jean-Jacques Bourguignon
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE60589T1 publication Critical patent/ATE60589T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87401562T 1986-07-03 1987-07-03 Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel. ATE60589T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8609681A FR2601011B1 (fr) 1986-07-03 1986-07-03 Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
EP87401562A EP0251937B1 (de) 1986-07-03 1987-07-03 Trizyklische Agonistenderivate von cholinergetischen Rezeptoren und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE60589T1 true ATE60589T1 (de) 1991-02-15

Family

ID=9337042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401562T ATE60589T1 (de) 1986-07-03 1987-07-03 Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel.

Country Status (16)

Country Link
US (1) US4977152A (de)
EP (1) EP0251937B1 (de)
JP (1) JPH029866A (de)
KR (1) KR880001614A (de)
AR (1) AR245123A1 (de)
AT (1) ATE60589T1 (de)
AU (1) AU602339B2 (de)
CA (1) CA1312864C (de)
DE (1) DE3767794D1 (de)
DK (1) DK162220C (de)
ES (1) ES2039256T3 (de)
FR (1) FR2601011B1 (de)
GR (1) GR3001646T3 (de)
NZ (1) NZ220926A (de)
PT (1) PT85234B (de)
ZA (1) ZA874846B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
KR100422589B1 (ko) * 2001-11-20 2004-03-16 (주)경인양행 셀룰로오스 섬유 또는 셀룰로오스 혼방섬유의 염색 방법
ATE523199T1 (de) * 2004-11-02 2011-09-15 Univ Northwestern Pyridazinverbindungen und verfahren
BRPI0517947A (pt) 2004-11-02 2008-10-21 Univ Northwestern composto de piridazina, composições e métodos
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
JP2009535344A (ja) 2006-04-28 2009-10-01 ノースウェスタン ユニバーシティ 神経炎症性疾患の処置のためのピリダジン化合物を含む処方物
US20110052643A1 (en) * 2008-01-07 2011-03-03 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2619818B1 (fr) * 1987-09-01 1990-01-12 Sanofi Sa Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DK162220C (da) 1992-03-02
PT85234A (fr) 1987-08-01
AU602339B2 (en) 1990-10-11
PT85234B (pt) 1990-04-30
AU7504987A (en) 1988-01-07
EP0251937B1 (de) 1991-01-30
CA1312864C (en) 1993-01-19
ZA874846B (en) 1988-03-30
KR880001614A (ko) 1988-04-25
DK340987D0 (da) 1987-07-02
JPH029866A (ja) 1990-01-12
NZ220926A (en) 1989-11-28
AR245123A1 (es) 1993-12-30
DK162220B (da) 1991-09-30
GR3001646T3 (en) 1992-11-23
FR2601011A1 (fr) 1988-01-08
FR2601011B1 (fr) 1988-10-28
ES2039256T3 (es) 1993-09-16
DE3767794D1 (de) 1991-03-07
US4977152A (en) 1990-12-11
DK340987A (da) 1988-01-04
EP0251937A1 (de) 1988-01-07

Similar Documents

Publication Publication Date Title
DE3770085D1 (de) Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel.
DE3689436D1 (de) Thiazolderivate und diese als wirksame Bestandteile enthaltender Leukotrien-Antagonist.
DE3769122D1 (de) Nitro-derivate von 2-iminoimidazolidinen und 2-iminotetrahydropyrimidinen.
DE3751845D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung
ATE109783T1 (de) 23-oxo(keto) und 23-imino-derivate von ll-f28249- verbindungen.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3750432D1 (de) IL-1 alpha Derivate und Medikamente.
DE3772789D1 (de) Halogen enthaltende heterozyklische verbindungen und diese enthaltende fluessigkristalline zusammensetzungen.
DK625087A (da) Heteroaromatiske aminoderivater dsamt laegemidler med indhold af saadanne forbindelser
DE3789294D1 (de) Triazin-Derivate und diese enthaltende Herbizide.
PT82985A (pt) Process for the preparation of distamycin derivatives and of pharmaceutical compositions containing the same
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE3770604D1 (de) Imidverbindung und diese enthaltende zusammensetzung.
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3767794D1 (de) Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel.
DE3750067D1 (de) Disazoverbindungen und diese Disazoverbindungen enthaltende Zubereitungen.
PT82901A (de) Arzneimittel und deren verwendung
FI875101A7 (fi) Laktaamijohdannaiset ja niitä sisältävät valmisteet.
FI852743A7 (fi) Asetyleenisiä fenoksipropanolijohdannaisia ja farmaseuttisia koostumuksia hypertoniahoitamiseksi.
DE3770718D1 (de) P-hydroxyzimtamid derivate und diese enthaltende melanininhibitoren.
DE3787669D1 (de) Substanz 4181-2 und deren Derivate.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee